3-(4-(1H-pyrazol-5-yl)phenyl)-N-(4-cyanophenyl)-N-methylimidazo[1,2-a]pyrazine-6-carboxamide

ID: ALA3325604

Chembl Id: CHEMBL3325604

PubChem CID: 90156896

Max Phase: Preclinical

Molecular Formula: C24H17N7O

Molecular Weight: 419.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C(=O)c1cn2c(-c3ccc(-c4ccn[nH]4)cc3)cnc2cn1)c1ccc(C#N)cc1

Standard InChI:  InChI=1S/C24H17N7O/c1-30(19-8-2-16(12-25)3-9-19)24(32)21-15-31-22(13-27-23(31)14-26-21)18-6-4-17(5-7-18)20-10-11-28-29-20/h2-11,13-15H,1H3,(H,28,29)

Standard InChI Key:  YEUDDPVZLPYOJS-UHFFFAOYSA-N

Associated Targets(non-human)

Plasmodium cynomolgi (553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium yoelii (6656 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.45Molecular Weight (Monoisotopic): 419.1495AlogP: 3.93#Rotatable Bonds: 4
Polar Surface Area: 102.97Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.97CX Basic pKa: 2.84CX LogP: 2.18CX LogD: 2.18
Aromatic Rings: 5Heavy Atoms: 32QED Weighted: 0.48Np Likeness Score: -1.86

References

1. Zou B, Nagle A, Chatterjee AK, Leong SY, Tan LJ, Sim WL, Mishra P, Guntapalli P, Tully DC, Lakshminarayana SB, Lim CS, Tan YC, Abas SN, Bodenreider C, Kuhen KL, Gagaring K, Borboa R, Chang J, Li C, Hollenbeck T, Tuntland T, Zeeman AM, Kocken CH, McNamara C, Kato N, Winzeler EA, Yeung BK, Diagana TT, Smith PW, Roland J..  (2014)  Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages.,  (8): [PMID:25147620] [10.1021/ml500244m]

Source